Results similar to those observed in our study regarding the reduced levels of sFasL in patients with TB were demonstrated by Schweizer et al. (2021) in patients with COVID-19 who had low levels of sFasL and were associated with a decrease in membrane Fas signaling and disease severity [47]. This evidence concerns the gene FAS and tuberculosis.